mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 73.3% | 13.6 / 12.2 | 30 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 1,551,119 | 0 | A | C | 62.5% | 9.4 / 13.0 | 16 | T80P (ACC→CCC) | osmC | peroxiredoxin OsmC |
| * | NZ_CP009273 | 349,999 | 0 | T | G | 60.0% | 5.6 / 26.0 | 25 | V528G (GTG→GGG) | prpE | propionate‑‑CoA ligase |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 60.0% | 0.8 / 21.5 | 30 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 642,666 | 0 | A | C | 58.3% | 7.4 / 10.4 | 12 | G100G (GGT→GGG) | citG | triphosphoribosyl‑dephospho‑CoA synthase CitG |
| * | NZ_CP009273 | 832,048 | 0 | T | G | 58.3% | 4.1 / 10.8 | 12 | V81G (GTC→GGC) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 2,621,984 | 0 | A | C | 58.3% | 3.8 / 10.6 | 12 | V105G (GTC→GGC) | pdeF | cyclic‑guanylate‑specific phosphodiesterase PdeF |
| * | NZ_CP009273 | 3,390,909 | 0 | A | C | 57.1% | 6.3 / 11.7 | 14 | G82G (GGT→GGG) | rng | ribonuclease G |
| * | NZ_CP009273 | 4,527,926 | 0 | A | C | 57.1% | 4.4 / 13.6 | 14 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
| * | NZ_CP009273 | 3,941,183 | 0 | T | G | 55.0% | 15.5 / 24.2 | 20 | T49P (ACC→CCC) | hdfR | HTH‑type transcriptional regulator HdfR |
| * | NZ_CP009273 | 497,036 | 0 | A | C | 53.8% | 5.7 / 12.4 | 13 | G553G (GGT→GGG) | ybaL | Kef family K(+) transporter |
| * | NZ_CP009273 | 3,254,414 | 0 | A | C | 52.6% | 13.7 / 23.5 | 19 | V455G (GTG→GGG) | tdcE | 2‑ketobutyrate formate‑lyase/pyruvate formate‑lyase |
| * | NZ_CP009273 | 350,029 | 0 | T | G | 52.2% | 20.2 / 29.8 | 23 | V538G (GTG→GGG) | prpE | propionate‑‑CoA ligase |
| * | NZ_CP009273 | 4,326,718 | 0 | T | A | 43.5% | 25.5 / 13.2 | 23 | Y44F (TAT→TTT) | adiC | arginine/agmatine antiporter |
| * | NZ_CP009273 | 3,740,492 | 0 | G | A | 39.5% | 41.2 / 13.4 | 39 | A17T (GCC→ACC) | lyxK | L‑xylulokinase |
| * | NZ_CP009273 | 3,751,028 | 0 | C | T | 35.7% | 23.7 / 11.0 | 28 | A54T (GCA→ACA) | yiaY | L‑threonine dehydrogenase |
| * | NZ_CP009273 | 2,860,603 | 0 | A | T | 35.5% | 36.5 / 10.5 | 31 | V103E (GTA→GAA) | rpoS | RNA polymerase sigma factor RpoS |
| * | NZ_CP009273 | 3,907,102 | 0 | G | . | 25.0% | 34.7 / 12.0 | 16 | intergenic (‑74/+88) | glmS/glmU | glutamine‑‑fructose‑6‑phosphate transaminase (isomerizing)/bifunctional UDP‑N‑acetylglucosamine diphosphorylase/glucosamine‑1‑phosphate N‑acetyltransferase GlmU |